The novel axis of YAP1, transcription enhancer factor 3 and Down Syndrome Candidate Region 1 isoform 1L is a common signaling pathway downstream of several angiogenic factors-Reference-Cited by-同舟云学术

The novel axis of YAP1, transcription enhancer factor 3 and Down Syndrome Candidate Region 1 isoform 1L is a common signaling pathway downstream of several angiogenic factors

Published:2020-05 Issue: Volume:129 Page:103955
ISSN:0026-2862
Container-title:Microvascular Research
language:en
Short-container-title:Microvascular Research

Author:

Cui Pengfei,Liu Xin,Zhao Kevin,Hou Shiqiang,Chen Chen,Zhao Dezheng,Zeng Huiyan

Funder

NIH

American Cancer Society

China Scholarship Council

Publisher

Elsevier BV

Subject

Cell Biology,Cardiology and Cardiovascular Medicine,Biochemistry

Reference39 articles.

1. Cancer: tumour stem cells switch sides;Bautch;Nature,2010

2. Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway;Chen;Protein Cell,2010

3. Hamster adapt78 mRNA is a Down syndrome critical region homologue that is inducible by oxidative stress;Crawford;Arch. Biochem. Biophys.,1997

4. Leaky tumor vessels: consequences for tumor stroma generation and for solid tumor therapy;Dvorak;Prog. Clin. Biol. Res.,1990

5. Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products;Dvorak;J. Immunol.,1979

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells;Microvascular Research;2022-03

2. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis;Microvascular Research;2021-11

3. RCAN1 in cardiovascular diseases: molecular mechanisms and a potential therapeutic target;Molecular Medicine;2020-12